Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

TSXV:MIR - Post Discussion

MedMira Inc > rapid-syphilis-testing as of june 1 2022
View:
Post by goldyhawk on Jun 23, 2022 9:49am

rapid-syphilis-testing as of june 1 2022

The rapid tests still need Health Canada approval before they can be used more widely, but the regulator has approved a second clinical trial to use the rapid tests in Saskatchewan.

The companies that would manufacture the products — one test by Medmira another by Biolytical Laboratories — have not yet received Health Canada approval.

https://www.cbc.ca/news/canada/edmonton/rapid-syphilis-testing-1.6461167

Comment by goldyhawk on Jun 24, 2022 8:01am
what concerns me is the need for a second clinical trial !!!! how many trials do they want ?????????????????????? indecision  abounds HC is happy with having  the appearance if doing something  and depending on  the FDA to show the way
Comment by PAIROF44 on Jun 25, 2022 11:41am
FDA get's 45% of his funding from Big Pharma.
Comment by goldyhawk on Jun 24, 2022 8:04am
what concerns me is the need for a second clinical trial !!!! how many trials do they want ?????????????????????? indecision  abounds HC is happy with having  the appearance of doing something  and depending on  the FDA to show the way
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities